Modular Medical (MODD) - חוב להון עצמי

Modular Medical (MODD) develops advanced insulin delivery systems, leveraging an extensive network of electronics suppliers to minimize component shortage risks. The business operates amidst fierce competition with global behemoths that possess vast resources and deep ties to insurers. This chart of the debt-to-equity ratio at 0.03 complements the picture of aggressive market capture through the intentional reduction of device costs.

The expansion of the Modular Medical (MODD) ecosystem in the US market requires a balance between aggressive market share acquisition among diabetics and financial stability. Analyzing the debt-to-equity chart, an investor assesses the proportion of borrowed funds relative to equity: an increasing ratio signals liquidity risks, whereas a decrease confirms the company's ability to scale available pumps without a critical debt burden.